Ionis Pharmaceuticals, Inc.
IONS
$55.34
-$0.68-1.21%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 2.10B | 1.98B | 2.68B | 2.24B | 2.29B |
| Total Receivables | 58.85M | 73.68M | 66.06M | 24.61M | 52.58M |
| Inventory | 50.83M | 5.56M | 10.05M | 10.47M | 8.48M |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 279.24M | 880.64M | 234.08M | 240.49M | 223.12M |
| Total Current Assets | 2.49B | 2.94B | 2.99B | 2.52B | 2.58B |
|
|
|||||
| Total Current Assets | 2.49B | 2.94B | 2.99B | 2.52B | 2.58B |
| Net Property, Plant & Equipment | 386.69M | 377.47M | 361.60M | 348.11M | 275.88M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 96.72M | 115.74M | 119.40M | 113.78M | 109.28M |
| Total Assets | 2.99B | 3.45B | 3.52B | 3.03B | 2.99B |
|
|
|||||
| Total Accounts Payable | 47.70M | 26.03M | 28.08M | 14.33M | 22.80M |
| Total Accrued Expenses | 166.07M | 162.60M | 222.33M | 156.33M | 145.52M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.92M | 443.43M | 454.69M | 644.89M | 652.92M |
| Total Finance Division Other Current Liabilities | 88.94M | 84.54M | 76.47M | 87.92M | 75.99M |
| Total Other Current Liabilities | 88.94M | 84.54M | 76.47M | 87.92M | 75.99M |
| Total Current Liabilities | 315.64M | 716.59M | 781.57M | 903.46M | 897.24M |
|
|
|||||
| Total Current Liabilities | 315.64M | 716.59M | 781.57M | 903.46M | 897.24M |
| Long-Term Debt | 1.91B | 1.91B | 1.90B | 1.14B | 1.17B |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 262.48M | 259.22M | 262.38M | 262.67M | 164.38M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 63.03M | 75.75M | 92.00M | 107.91M | 125.10M |
| Total Liabilities | 2.55B | 2.96B | 3.03B | 2.42B | 2.35B |
|
|
|||||
| Common Stock & APIC | 3.31B | 3.25B | 3.15B | 3.05B | 2.93B |
| Retained Earnings | -2.84B | -2.72B | -2.63B | -2.40B | -2.27B |
| Treasury Stock & Other | -33.90M | -31.02M | -25.28M | -25.98M | -27.99M |
| Total Common Equity | 439.74M | 491.41M | 489.09M | 617.97M | 631.72M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 439.74M | 491.41M | 489.09M | 617.97M | 631.72M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 439.74M | 491.41M | 489.09M | 617.97M | 631.72M |
|
|
|||||